CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2005-02-03): Roche's Pegasys wins EU approval for HIV patients

Regulatory

Roche's Pegasys wins EU approval for HIV patients

Last Updated: 2005-02-03 15:55:27 -0400 (Reuters Health)

ZURICH (Reuters) - Roche Holding AG's Pegasys hepatitis treatment has won approval from European authorities for use in HIV patients who also have hepatitis C, the Swiss drug maker said on Thursday.

Roche said that Pegasys, in combination with ribavirin, was the first hepatitis C treatment to be given the green light for use in co-infected patients.

The decision had been expected after a European Union medical panel gave a positive recommendation on the use of the drug in patients with HIV. Some 30% of patients with HIV are thought to also be infected with hepatitis C, Roche said.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.